0001437749-24-000484.txt : 20240103
0001437749-24-000484.hdr.sgml : 20240103
20240103193831
ACCESSION NUMBER: 0001437749-24-000484
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231231
FILED AS OF DATE: 20240103
DATE AS OF CHANGE: 20240103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KLAUSNER ARTHUR J
CENTRAL INDEX KEY: 0001207790
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39070
FILM NUMBER: 24509220
MAIL ADDRESS:
STREET 1: ONE PALMER SQUARE
CITY: PRINCETON
STATE: NJ
ZIP: 08542
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Monopar Therapeutics
CENTRAL INDEX KEY: 0001645469
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 320463781
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1000 SKOKIE BLVD SUITE 350
CITY: WILMETTE
STATE: IL
ZIP: 60091
BUSINESS PHONE: 8473880349
MAIL ADDRESS:
STREET 1: 1000 SKOKIE BLVD SUITE 350
CITY: WILMETTE
STATE: IL
ZIP: 60091
4
1
rdgdoc.xml
FORM 4
X0508
4
2023-12-31
0001645469
Monopar Therapeutics
MNPR
0001207790
KLAUSNER ARTHUR J
1000 SKOKIE BLVD SUITE 350
WILMETTE
IL
60091
1
0
Common Stock
2023-12-31
4
M
0
2533
A
30863
D
Common Stock
3055394.12
I
See Footnote
Restricted Stock Units
2023-12-31
4
M
0
2533
0
D
Common Stock
2533
0
D
Represents shares acquired on vesting and settlement of restricted stock units.
This is based upon the 3,055,394.12 shares of Monopar common stock that Gem Pharmaceuticals, LLC, indirectly controls through TacticGem LLC. As a manager of Gem Pharmaceuticals, LLC, Mr. Klausner may be deemed to share voting and dispositive power over these 3,055,394.12 shares. Mr. Klausner disclaims beneficial ownership of the 3,055,394.12 shares held by Gem Pharmaceuticals, LLC, except to the extent of his pecuniary interest therein.
On February 1, 2023, the reporting person was granted 10,133 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.
/s/ Kim R. Tsuchimoto, Attorney-in-fact
2024-01-03